Elite Pharmaceuticals (ELTP) Cost of Revenue (2010 - 2026)
Elite Pharmaceuticals (ELTP) recorded Cost of Revenue of $18.85 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 45.1% from $12.99 million a year earlier but down 5.6% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Cost of Revenue (2010 - 2026) Analysis & Trends
On a TTM basis, Elite Pharmaceuticals' Cost of Revenue came in at $79.71 million as of Jun 30, 2026, up 71.0% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $73.85 million, up 68.0% from FY2025.
- Annual Cost of Revenue has increased for eight straight fiscal years, with a five-year compound annual growth rate of 40.4% (FY2021 to FY2026).
- Across earlier fiscal years, Cost of Revenue came in at $43.96 million in FY2025 (+45.2%), $30.27 million in FY2024 (+72.4%), $17.56 million in FY2023 (+0.5%) and $17.47 million in FY2022 (+29.3%).
- Quarterly Cost of Revenue has ranged from $3.68 million in fiscal Q1 2023 to $22.25 million in fiscal Q2 2026 over the past five years.
- On a year-over-year basis, Cost of Revenue has increased for six consecutive quarters, with growth averaging 53.3% over the last eight quarters.
- Peak year-over-year performance for Cost of Revenue in the last five years was growth of 144.2% in fiscal Q1 2025, against a decline of 12.6% in fiscal Q3 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $19.98 million (Q4 2026), $18.64 million (Q3 2026) and $22.25 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Elite Pharmaceuticals | 269.28 Mn | 150.96 Mn | 13.51 Mn | 18.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.85 Mn |
| Mar 31, 2026 | 19.98 Mn |
| Dec 31, 2025 | 18.64 Mn |
| Sep 30, 2025 | 22.25 Mn |
| Jun 30, 2025 | 12.99 Mn |
| Mar 31, 2025 | 14.70 Mn |
| Dec 31, 2024 | 8.24 Mn |
| Sep 30, 2024 | 10.68 Mn |
| Jun 30, 2024 | 10.33 Mn |
| Mar 31, 2024 | 9.83 Mn |
| Dec 31, 2023 | 8.50 Mn |
| Sep 30, 2023 | 7.71 Mn |
| Jun 30, 2023 | 4.23 Mn |
| Mar 31, 2023 | 5.20 Mn |
| Dec 31, 2022 | 4.33 Mn |
| Sep 30, 2022 | 4.76 Mn |
| Jun 30, 2022 | 3.68 Mn |
| Mar 31, 2022 | 4.26 Mn |
| Dec 31, 2021 | 4.96 Mn |
| Sep 30, 2021 | 4.79 Mn |
API Access
Elite Pharmaceuticals Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();